Product Overview

Cap GAU is a high-purity GMP-grade mRNA capping reagent manufactured in a GMP-compliant production environment with a completely animal origin-free process throughout the entire workflow. It is designed for in vitro transcription (IVT), nucleic acid drug development, and large-scale mRNA manufacturing applications.

With stringent quality control, excellent purity, and high batch-to-batch consistency, Cap GAU supports the development and production of high-quality capped mRNA products. It is suitable for a wide range of applications, including mRNA vaccine development, gene therapy research, and GMP-scale mRNA manufacturing, covering the entire workflow from preclinical research to commercial production.

Key Features

GMP-Grade Manufacturing

Cap GAU is manufactured under a GMP-compliant production environment with comprehensive quality control standards to ensure reliable quality and consistent performance for mRNA therapeutic development and manufacturing.

High Purity and Reliable Performance

With a purity of >98%, Cap GAU is produced using optimized purification processes to minimize impurities and provide high-quality raw materials for mRNA synthesis workflows.

Ultra-Low Metal Residue Control

Strict control of metal residue levels helps maintain reagent quality and supports efficient enzymatic reactions during mRNA production processes.

Animal Origin-Free Processing

The complete manufacturing workflow adopts an animal origin-free process, supporting the safety, compliance, and quality requirements of biopharmaceutical applications.

Excellent Batch-to-Batch Consistency

Advanced manufacturing processes and rigorous analytical testing ensure stable product quality and reproducible performance between batches.

Regulatory Support and Customization Options

DMF filing support is available. A complete range of mRNA capping reagents is provided, with customized specifications and packaging solutions available to meet different development and manufacturing needs.

Applications

Cap GAU is suitable for applications involving mRNA synthesis and therapeutic development, including:

• mRNA vaccine development and GMP manufacturing

• Gene therapy drug research and development

• In vitro transcription (IVT) mRNA synthesis

• Nucleic acid drug discovery and development

• mRNA process development and optimization

• Preclinical research and commercial-scale production

Cap GAU supports the complete mRNA therapeutic development pipeline, from early research and process optimization to GMP-scale manufacturing.

FAQ

Q1: What is Cap GAU used for?

Cap GAU is an mRNA capping reagent designed for in vitro transcription (IVT) and mRNA manufacturing workflows. It is used in applications such as mRNA vaccine development, gene therapy research, and nucleic acid drug production.

Q2: Is Cap GAU suitable for GMP-scale mRNA manufacturing?

Yes. Cap GAU is produced in a GMP-compliant manufacturing environment with strict quality control and supports applications from preclinical development to commercial-scale mRNA production.

Q3: Is Cap GAU manufactured using animal-derived materials?

No. Cap GAU is manufactured using a completely animal origin-free production process throughout the entire workflow.

Q4: What is the purity of Cap GAU?

The purity of Cap GAU is greater than 98%, ensuring high-quality performance for mRNA synthesis and capping applications.

Q5: Does Cap GAU support regulatory documentation?

Yes. DMF filing support is available to assist customers with regulatory and pharmaceutical development requirements.

Q6: How should Cap GAU be transported and stored?

Cap GAU should be transported under temperature-controlled conditions below 0°C and stored at -25°C to -15°C to maintain product stability and performance.

Q7: Can customized product solutions be provided?

Yes. Customized product specifications, packaging formats, and supply solutions can be provided according to customer research and manufacturing requirements.

Related Products